Vaccination Coverage of Children with Epidermolysis Bullosa Against Vaccine Preventable Diseases According to National Preventive Vaccination Programmes: Cross-Sectional Study

Background. Patients with epidermolysis bullosa (EB) have higher risk of developing infectious diseases. Its prevention requires timely vaccination. For now, there are no studies showing vaccination coverage for this category of children. Objective. Our aim was to study vaccination coverage of children with EB according to national preventive vaccination programmes. Methods. This retrospective cross-sectional study examined medical records of patients with EB from Russian Federation and neighbouring countries. Vaccination coverage (completeness and timeliness) and age of immunization initiation were analyzed. Moreover, we have studied the spectrum of early post-vaccine reactions and the course of the post-vaccine period in children with EB vaccinated for the first time. Results. The study included medical records of 134 patients with EB aged from 8 months to 17 years 8 months. Vaccination was performed according to national immunization programs in 37 (28%) children, only 21 cases were carried out in a timely manner. Medical exemptions were the major reason for the refusal of vaccination in most cases (82%). 48 patients with EB were vaccinated against 12 vaccine preventable diseases in the hospital. The post-vaccine period was asymptomatic in 36 (76%) patients, 10 (20%) patients had tenderness and hyperemia at the injection site, 2 (4%) patients had subfebrile fever. Conclusion. Most children with EB are still unvaccinated or vaccinated untimely. Immunization of such children against vaccine preventable disease according to the individual plan can be pretty useful.

1. Federal Law dated November 21, 2011 N 323-ФЗ “Ob osnovakh okhrany zdorov'ya grazhdan v Rossiiskoi Federatsii”. (In Russ). Доступно по: minzdrav.gov.ru/7025. Ссылка активна на 28.10.2021.

2. Namazova-Baranova LS, Fedoseenko MV, Baranov AA. New Horizons of National Immunization Calendar. Voprosy sovremennoi pediatrii — Current Pediatrics. 2019;18(1):13-30. (In Russ). doi: 10.15690/vsp.v18i1.1988

3. Kaliuzhnaia TA, Fedoseenko MV, Namazova-Baranova LS, et al. Overcoming ‘Anti-Vaccination Scepticism': Seeking a Solution to the Situation. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2018;15(2):141-148. (In Russ). doi: 10.15690/pf.v15i2.1871

4. Prevention of severe infections in patients with genetic disorders of the complement system regulation treating with eculizumab: Press release on the Interdisciplinary expert council meeting. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2017;14(1):66-72. (In Russ).

5. Esposito S, Cerutti M, Milani D, et al. Vaccination coverage of children with rare genetic diseases and attitudes of their parents toward vaccines. Hum Vaccin Immunother. 2016;12(3):801-805. doi: 10.1080/21645515.2015.1086046

6. Alexeeva EI, Dvoryakovskaya ТМ, Denisova RV, et al. Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis Without Systemic Manifestations: a Prospective Study. Voprosy sovremennoi pediatrii — Current Pediatrics. 2017;16(6):493-501. (In Russ). doi: 10.15690/vsp.v16i6.1822

7. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309-318. doi: 10.1093/cid/cit816

8. Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: update recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70(6):1103-1126. doi: 10.1016/j.jaad.2014.01.903

9. Uttito J, Pulkkinen L. Molecular genetics of heritable blistering disoders. Arch Dermatol. 2001;137(11):1458-1461. doi: 10.1001/archderm.137.11.1458.

10. Bulleznyi epidermoliz: Guide for doctors. Murashkin NN, Namazova-Baranova LS, eds. Moscow: Pediatr; 2019. (In Russ).

11. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61(3):367-384; quiz 385-386. doi: 10.1016/j.jaad.2009.03.052

12. Brandling-Bennett HA, Morel KD. Common wound colonizers in patients with epidermolysis bullosa. Pediatr Dermatol. 2010;27(1):25-28. doi: 10.1111/j.1525-1470.2009.01070.x

13. Mellerio JE. Infection and colonization in epidermolysis bullosa. Dermatol Clin. 2010;28(2):267-269, ix. doi: 10.1016/j.det.2010.01.004

14. Makarova SG, Namazova-Baranova LS, Murashkin NN, et al. Correction of Nutritional Status in Complex Therapy for Children Suffering from Dystrophic Forms of Innate Epidermolysis Bullosa. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2016;13(6):577-586. (In Russ). doi: 10.15690/pf.v13i6.1672

15. Hachem M, Zambruno G, Bourdon-Lanoy E, et al. Multicentre consensuns recommendation for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis. 2014;9:76. doi: 10.1186/1750-1172-9-76

16. Boeira VL, Souza ES, Rocha Bde O, et al. Inherited epidermolysis bullosa: clinical and therapeutic aspects. An Bras Dermatol. 2013;88(2):185-198. doi: 10.1590/S0365-05962013000200001

17. Sianez-Gonzalez C, Pezoa-Jares R, Salas-Alanis JC. Congenital epidermolysis bullosa: a review. Actas Dermosifiliogr. 2009;100(10):842-856.

18. National calendar of preventive vaccinations in Russia. (In Russ). Доступно по: https://www.rospotrebnadzor.ru/bitrix/redirect.php?event1=file&event2=download&event3=natskalend ar-porfprivivok-2014.doc&goto=/upload/iblock/d12/natskalendar-porfprivivok-2014.doc. Ссылка активна на 28.10.2021.

19. National vaccination calendar of the Republic of Azerbaijan. (In Russ). Доступно по: https://ambulatoriya.net/child-care/index. Ссылка активна на: 28.10.2021.

20. Resolution of the Government of the Republic of Kazakhstan dated February 12, 2013 N 119 “O vnesenii izmenenii i dopolnenii v postanovlenie Pravitel'stva Respubliki Kazakhstan ot 30 dekabrya 2009 g. N 2295 “Ob utverzhdenii perechnya zabolevanii, protiv kotorykh provodyatsya profilakticheskie privivki, Pravil ikh provedeniya i grupp naseleniya, podlezhashchikh planovym privivkam”. (In Russ). Доступно по: https://government.kz/ru/decisions/12022013-119. Ссылка активна на 28.10.2021.

21. Resolution of the Government of the Republic of Tajikistan dated October 28, 2016 N 456. “O Natsional'noi programme immunoprofilaktiki v Respublike Tadzhikistan na 20162020 gody”. (In Russ). Доступно по: https://base.spinform.ru/show_doc.fwx?rgn=90480#A4S10T35DN. Ссылка активна на 28.10.2021.

22. Sanitary rules, norms and hygienic standards of the Republic of Uzbekistan dated September 22, 2015 N 0239-07 (addition N 3) “Immunoprofilaktika infektsionnykh zabolevanii v Respublike Uzbekistan”. (In Russ). Доступно по: https://nrm.uz/products?folder=411112_sanitarnye_normy_i_pravila&products=1_vse_zakonodatelstvo_uzbekistana. Ссылка активна на 28.10.2021.

23. Potekaev NN, Zhukova OV, Porshina OV, Chasova GK. Clinical and epidemiological features of the congenital epidermolysis bullosa in Moscow. Klinicheskaya Dermatologiya i Venerologiya. 2017;16(6):83-89. (In Russ). doi: 10.17116/klinderma201716683-89